Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2379]

BGICC 2019 ( )

APT for HER2 breast cancer patients with small tumours

Prof Nagi El Saghir - American University of Beirut, Beirut, Lebanon

APT for HER2 breast cancer patients with small tumours ( Prof Nagi El Saghir - American University of Beirut, Beirut, Lebanon )

History and current status of breast cancer treatment in Sweden

Prof Kerstin Sandelin - Karolinska Institutet, Solna, Sweden

History and current status of breast cancer treatment in Sweden ( Prof Kerstin Sandelin - Karolinska Institutet, Solna, Sweden )

Shortening the time taken to get breast cancer patients diagnosed in Latin...

Dra Cynthia Villareal-Garzia - Monterrey Institute of Technology, Monterrey...

Shortening the time taken to get breast cancer patients diagnosed in Latin America ( Dra Cynthia Villareal-Garzia - Monterrey Institute of Technology, Monterrey, Mexico )

Regional radiation benefits high risk breast cancer patients

Prof David Dodwell - Nuffield Department of Population Health, Oxford, UK

Regional radiation benefits high risk breast cancer patients ( Prof David Dodwell - Nuffield Department of Population Health, Oxford, UK )

Polygenic risk scores for breast cancer: ready or not?

Prof Gareth Evans - University of Manchester, Manchester, UK

Polygenic risk scores for breast cancer: ready or not? ( Prof Gareth Evans - University of Manchester, Manchester, UK )

Single cell genomics in breast cancer: breast tumour evolution and intra-tumour...

Dr Nicholas Navin - MD Anderson Cancer Center, Houston, USA

Single cell genomics in breast cancer: breast tumour evolution and intra-tumour heterogeneity ( Dr Nicholas Navin - MD Anderson Cancer Center, Houston, USA )

SABCS 2018: Highlights in breast cancer treatment

Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy

SABCS 2018: Highlights in breast cancer treatment ( Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy )

Prognostic value of circulating tumour-cell count in metastatic breast cancer...

Dr Francois-Clement Bidard - Institut Curie, Paris, France

Prognostic value of circulating tumour-cell count in metastatic breast cancer patients ( Dr Francois-Clement Bidard - Institut Curie, Paris, France )

Clinical impact of an accurate genetic characterisation of older AML patients

Prof Alessandro Rambaldi - University of Milan, Milan, Italy

Clinical impact of an accurate genetic characterisation of older AML patients ( Prof Alessandro Rambaldi - University of Milan, Milan, Italy )

Circulating tumour-cell count used to decide between treatments for breast...

Dr Francois-Clement Bidard - Institut Curie, Paris, France

Circulating tumour-cell count used to decide between treatments for breast cancer patients ( Dr Francois-Clement Bidard - Institut Curie, Paris, France )

Accelerated partial breast irradiation not equivalent to whole breast...

Dr Frank Vicini - St Joseph Mercy Oakland, Pontiac, USA

Accelerated partial breast irradiation not equivalent to whole breast irradiation ( Dr Frank Vicini - St Joseph Mercy Oakland, Pontiac, USA )

More from ecancer